HCI-2184 is a Nek2 inhibitor with an IC 50 of 39.90 nM. HCI-2184 significantly increases the effectiveness of Bortezomib ( HY-10227 ) in inhibiting proteasome activity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > NEKs
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.